Literature DB >> 16357012

Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise.

Graham P Holloway1, Veronic Bezaire, George J F Heigenhauser, Narendra N Tandon, Jan F C Glatz, Joost J F P Luiken, Arend Bonen, Lawrence L Spriet.   

Abstract

Mitochondrial fatty acid transport is a rate-limiting step in long chain fatty acid (LCFA) oxidation. In rat skeletal muscle, the transport of LCFA at the level of mitochondria is regulated by carnitine palmitoyltransferase I (CPTI) activity and the content of malonyl-CoA (M-CoA); however, this relationship is not consistently observed in humans. Recently, fatty acid translocase (FAT)/CD36 was identified on mitochondria isolated from rat and human skeletal muscle and found to be involved in LCFA oxidation. The present study investigated the effects of exercise (120 min of cycling at approximately 60% V(O2peak)) on CPTI palmitoyl-CoA and M-CoA kinetics, and on the presence and functional significance of FAT/CD36 on skeletal muscle mitochondria. Whole body fat oxidation rates progressively increased during exercise (P < 0.05), and concomitantly M-CoA inhibition of CPTI was progressively attenuated. Compared to rest, 120 min of cycling reduced (P < 0.05) the inhibition of 0.7, 2, 5 and 10 microM M-CoA by 16%, 21%, 30% and 34%, respectively. Whole body fat oxidation and palmitate oxidation rates in isolated mitochondria progressively increased (P < 0.05) during exercise, and were positively correlated (r = 0.78). Mitochondrial FAT/CD36 protein increased by 63% (P < 0.05) during exercise and was significantly (P < 0.05) correlated with mitochondrial palmitate oxidation rates at all time points (r= 0.41). However, the strongest (P < 0.05) correlation was observed following 120 min of cycling (r = 0.63). Importantly, the addition of sulfo-N-succimidyloleate, a specific inhibitor of FAT/CD36, reduced mitochondrial palmitate oxidation to approximately 20%, indicating FAT/CD36 is functionally significant with respect to LCFA oxidation. We hypothesize that exercise-induced increases in fatty acid oxidation occur as a result of an increased ability to transport LCFA into mitochondria. We further suggest that decreased CPTI M-CoA sensitivity and increased mitochondrial FAT/CD36 protein are both important for increasing whole body fatty acid oxidation during prolonged exercise.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357012      PMCID: PMC1805655          DOI: 10.1113/jphysiol.2005.102178

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  30 in total

Review 1.  The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis.

Authors:  J D McGarry; N F Brown
Journal:  Eur J Biochem       Date:  1997-02-15

2.  Inhibition of platelet adhesion to collagen by monoclonal anti-CD36 antibodies.

Authors:  K Matsuno; M Diaz-Ricart; R R Montgomery; R H Aster; G A Jamieson; N N Tandon
Journal:  Br J Haematol       Date:  1996-03       Impact factor: 6.998

3.  Time course of exercise-induced decline in malonyl-CoA in different muscle types.

Authors:  W W Winder; J Arogyasami; I M Elayan; D Cartmill
Journal:  Am J Physiol       Date:  1990-08

4.  Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A.

Authors:  W W Winder; H A Wilson; D G Hardie; B B Rasmussen; C A Hutber; G B Call; R D Clayton; L M Conley; S Yoon; B Zhou
Journal:  J Appl Physiol (1985)       Date:  1997-01

5.  Demonstration of N- and C-terminal domain intramolecular interactions in rat liver carnitine palmitoyltransferase 1 that determine its degree of malonyl-CoA sensitivity.

Authors:  Audrey Faye; Karen Borthwick; Catherine Esnous; Nigel T Price; Stéphanie Gobin; Vicky N Jackson; Victor A Zammit; Jean Girard; Carina Prip-Buus
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

6.  Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise.

Authors:  Carsten Roepstorff; Nils Halberg; Thore Hillig; Asish K Saha; Neil B Ruderman; Jørgen F P Wojtaszewski; Erik A Richter; Bente Kiens
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-09-21       Impact factor: 4.310

7.  Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36.

Authors:  N A Abumrad; M R el-Maghrabi; E Z Amri; E Lopez; P A Grimaldi
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

8.  Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat.

Authors:  J D McGarry; S E Mills; C S Long; D W Foster
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

9.  Skeletal muscle malonyl-CoA content at the onset of exercise at varying power outputs in humans.

Authors:  L M Odland; R A Howlett; G J Heigenhauser; E Hultman; L L Spriet
Journal:  Am J Physiol       Date:  1998-06

10.  Human skeletal muscle malonyl-CoA at rest and during prolonged submaximal exercise.

Authors:  L M Odland; G J Heigenhauser; G D Lopaschuk; L L Spriet
Journal:  Am J Physiol       Date:  1996-03
View more
  55 in total

1.  Exercise training reverses impaired skeletal muscle metabolism induced by artificial selection for low aerobic capacity.

Authors:  Sarah J Lessard; Donato A Rivas; Erin J Stephenson; Ben B Yaspelkis; Lauren G Koch; Steven L Britton; John A Hawley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-03       Impact factor: 3.619

2.  Reply from Arend Bonen, Hideo Hatta, Graham P. Holloway, Lawrence L. Spriet and Yuko Yoshida.

Authors:  Arend Bonen; Hideo Hatta; Graham P Holloway; Lawrence L Spriet; Yuko Yoshida
Journal:  J Physiol       Date:  2007-10-15       Impact factor: 5.182

3.  Regulation of fatty acid transport: from transcriptional to posttranscriptional effects.

Authors:  Adrian Chabowski; Jan Górski; Arend Bonen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-07       Impact factor: 3.000

Review 4.  Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands.

Authors:  Valdur Saks; Roland Favier; Rita Guzun; Uwe Schlattner; Theo Wallimann
Journal:  J Physiol       Date:  2006-09-28       Impact factor: 5.182

Review 5.  New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle.

Authors:  Francis B Stephens; Dumitru Constantin-Teodosiu; Paul L Greenhaff
Journal:  J Physiol       Date:  2007-03-01       Impact factor: 5.182

6.  Regulation of substrate use during the marathon.

Authors:  Lawrence L Spriet
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

7.  Calpain 10 homology modeling with CYGAK and increased lipophilicity leads to greater potency and efficacy in cells.

Authors:  Matthew A Smith; Campbell McInnes; Ryan M Whitaker; Christopher C Lindsey; Richard F Comer; Craig C Beeson; Rick G Schnellmann
Journal:  ACS Chem Biol       Date:  2012-05-31       Impact factor: 5.100

Review 8.  Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise.

Authors:  Lorraine P Turcotte; Jonathan S Fisher
Journal:  Phys Ther       Date:  2008-09-18

9.  The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes.

Authors:  Philip L Hooper; Gabor Balogh; Eric Rivas; Kylie Kavanagh; Laszlo Vigh
Journal:  Cell Stress Chaperones       Date:  2014-02-13       Impact factor: 3.667

10.  Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle.

Authors:  Graham P Holloway; Jamie Lally; James G Nickerson; Hakam Alkhateeb; Laelie A Snook; George J F Heigenhauser; Jorge Calles-Escandon; Jan F C Glatz; Joost J F P Luiken; Lawrence L Spriet; Arend Bonen
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.